Crucial characteristics such as acute toxicity and the steadiness of new inhibitors
Dabigatran etexilat was authorized recently as the 1st small molecule thrombin inhibitor for peroral introduction. Therefore, the development of effective new immediate thrombin inhibitors is a really important goal for…